Cowen Downgrades Apollo Endosurgery (APEN) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts APEN Hot Sheet
Price: $10.00 --0%
Rating Summary:
3 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 21 | New: 12
Rating Summary:
3 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 21 | New: 12
Join SI Premium – FREE
Cowen analyst Jashua Jennings downgraded Apollo Endosurgery (NASDAQ: APEN) from Outperform to Market Perform with a price target of $10.00 (from $13.00).
For an analyst ratings summary and ratings history on Apollo Endosurgery click here. For more ratings news on Apollo Endosurgery click here.
Shares of Apollo Endosurgery closed at $9.84 yesterday.
You May Also Be Interested In
- Amgen (AMGN) PT Raised to $465 at Cantor Fitzgerald
- Amgen (AMGN) PT Raised to $531 at TD Cowen
- Apollo Global Management (APO) PT Lowered to $136 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
